Company · CIK 1664106
LogicBio Therapeutics, Inc.
| CIK | 1664106 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2018-12-03 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-234735 | 2019-11-15 | 2022-11-18 | 5 | |
| 333-227523 | 2018-09-25 | 2018-10-22 | 6 |
Filings
12| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2022-11-18 | EFFECTDeclared effective | 333-234735 | 9999999995-22-003341 |
| 2020-10-02 | 424B5Shelf takedown | 333-234735 | 0001193125-20-262477 |
| 2020-09-30 | 424B5Shelf takedown | 333-234735 | 0001193125-20-259681 |
| 2019-11-25 | EFFECTDeclared effective | 333-234735 | 9999999995-19-002659 |
| 2019-11-15 | S-3Shelf registered | 333-234735 | 0001193125-19-293465 |
| 2018-10-22 | 424B4Final prospectus | 333-227523 | 0001193125-18-303289 |
| 2018-10-18 | EFFECTDeclared effective | 333-227523 | 9999999995-18-002661 |
| 2018-10-17 | S-1/AAmendment | 333-227523 | 0001193125-18-301103 |
| 2018-10-11 | S-1/AAmendment | 333-227523 | 0001193125-18-297645 |
| 2018-10-09 | S-1/AAmendment | 333-227523 | 0001193125-18-295666 |
| 2018-09-25 | S-1Registration filed | 333-227523 | 0001193125-18-282629 |
| 2018-08-13 | DRSDraft made public | 377-02214 | 0000950123-18-008157 |